{"id":793265,"date":"2024-12-09T06:33:27","date_gmt":"2024-12-09T11:33:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/medirom-healthcare-technologies-has-received-orders-for-over-25000-mother-bracelet-units\/"},"modified":"2024-12-09T06:33:27","modified_gmt":"2024-12-09T11:33:27","slug":"medirom-healthcare-technologies-has-received-orders-for-over-25000-mother-bracelet-units","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/medirom-healthcare-technologies-has-received-orders-for-over-25000-mother-bracelet-units\/","title":{"rendered":"MEDIROM Healthcare Technologies Has Received\u00a0Orders for Over 25,000 MOTHER Bracelet Units"},"content":{"rendered":"
\n

TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (\u201cMEDIROM\u201d) announces that its subsidiary MEDIROM MOTHER Labs Inc. has received\u00a0orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc.<\/p>\n

\u201cOur long-term mission is for the Mother Bracelet to be revolutionary in the Healthcare Technology and Wellness industries. The 25,000 unit MOTHER Bracelet orders surpasses the amount we\u2019ve received and fulfilled to date and shows the continued momentum of our market penetration. Furthermore, we believe such orders received from not only NFES Technologies but also two other major companies listed on the Tokyo Stock Exchange further validates the commercialization of our technology,\u201d said Kouji Eguchi, CEO, MEDIROM.<\/p>\n

About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku\u00ae being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called \u201cLav\u00ae\u201d, which is developed by MEDIROM. MEDIROM also entered the device business in 2020 and has developed a smart tracker \u201cMOTHER Bracelet\u00ae\u201d. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https:\/\/medirom.co.jp\/en.<\/p>\n

Contact:
Investor Relations Team
E-mail:ir@medirom.co.jp<\/u><\/a><\/p>\n

Free Writing Prospectus Statement<\/p>\n

This free writing prospectus relates to the public offering of American Depositary Shares representing common shares of MEDIROM Healthcare Technologies Inc. (the \u201cCompany\u201d) and should be read together with the preliminary prospectus dated December 4, 2024 (the \u201cPreliminary Prospectus\u201d) that was included in Amendment No. 3 to the Registration Statement on Form F-1 (File No. 333-281771), which can be accessed through the following web link:<\/p>\n

\n https:\/\/www.sec.gov\/Archives\/edgar\/data\/1819704\/000110465924125282\/tm2422156-10_f1a.htm<\/a>\n <\/p>\n

The Company has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting ThinkEquity LLC at (877) 436-3673 or by email at prospectus@think-equity.com.<\/p>\n

Forward-Looking Statements Regarding MEDIROM<\/p>\n

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM\u2019s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cdesign,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201chope,\u201d \u201cexpect,\u201d \u201ccould,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cpotential,\u201d \u201cgoal,\u201d or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM\u2019s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM\u2019s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM\u2019s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM\u2019s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM\u2019s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:<\/p>\n